Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 198 participants.
Also called NCT06364215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 198 participants
- Sponsor
- Registry
-
NCT06364215
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT06364215. Randomized; double masking; primary purpose treatment. Start 2024-10-08 (actual); primary completion 2025-11-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
- Acronym
- (SMILE-AF)
- Condition
- Atrial Fibrillation Paroxysmal
- Intervention (Device)
- Farapulse PFA, Pulmonary Vein Isolation alone
- Intervention (Device)
- Farapulse PFA, Pulmonary Vein Isolation and Left atrial Posterior Wall Isolation
- Lead sponsor
- Jorge Romero
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Databean
Record details
- Record id
cardio:ct-nct06364215- Content hash
0ed130256505f3d2cb9cc64f3375837ca719eb48ed057efb0e47c5a993e49e9f